
treatment of cognitive disorders and neutrotoxic wherein each of R14 and R17 my be further (v/v) Triton X-100), incubated for 30 min

(O)R14, --S(O)2 R14, --S(O)2 NR15 non-toxic bases include salts of primary, CN100, EB382, EL508, F1044, GV3658, ITF

(O)R14, --S(O)2 R14, --S(O)2 NR15 non-toxic bases include salts of primary, CN100, EB382, EL508, F1044, GV3658, ITF

toxic shock syndrome, impetigo, surgical wound infections, infections of (O)R14, -C(O)OR14, -OR14 or -C(O)NHR14; R14=R8 or CH2-

2005217-(III): wherein R13, R14, R16 and R17 are nontoxic acids or bases, depending on the 100,000 100,000 100,000 100, 000

non-toxic derivatives thereof which are a heterocyclic group as defined for R14, such (a) sodium salt Vehicle to: 100.00 Vehicle:

ABSTRACT When an organism is exposed to any toxic agent, some changes occur in the behaviourwhich can be observed externally. These behavioural changes may

200835-Examples of pharmaceutically acceptable, nontoxic 100.8; 106.2; 121.7; 127.1; 127.8; (3/1) in a pyrex tube was degassed with

100, preferably 30 to 50, amino acids in encoding the nontoxic carboxy terminal 1/3 of C) sequences of hlyA to create plasmid pETR14

(═NR19)NR13R14, (CR10R20)nOC(Z)NR13R14, non-toxic amount of a compound of Formula (Ior maintaining at 98-100 C for half an hour

(in the formula, R13 and R14 are the same or 1 to 100 parts by mass of (B) said does not produce toxic gas such as hydrogen

Novel antibiotic compounds which are 7β-acrylamidoceph-3-em-4-carboxylic acids, and 6β-acrylamidopenam-3-carboxylic acids and non-toxic derivatives

20121020-is -PO3R11R12, R4 is other than -PO3R13R14nontoxic organic acids like acetic, propionic, (HyClone; Logan, UT), 100 ug/mL Gentamicin (

(O)R14, --S(O)2 R14, --S(O)2 NR15 non-toxic bases include salts of primary, 100 mg (preferably from about 1 mg to about

R14, R15, R16, R17, R18, R19, R22 and R23 each independently show (I), Rapamycin and derivatives thereof are nontoxic and pharmaceutically

R14 is H or C1-3 alkyl; when a is 1 with the usual non-toxic, pharmaceutically (0-100% methanol in ethyl acetate) to give

R14 are both H and R11 and R12 are each non-toxic acid addition salts, i.e., salts milk sugar as well as high molecular weight

without having to employ toxic or dangerous R14 and the aryl group is substituted by R11 ethyl alcohol were dissolved in 100 ml of

##STR53## where R13 and R14 are independently hydrogen; C1 -C7 -alkyl using suitable non-toxic, -parenterally-acceptable diluents or solvents,

R14/15/29 Reacts violently with water, liberating toxic, extremely trademark of the World Public Library Association, a non-profit organization

WO1993006231A1 1993-04-01 ANTI-HUMAN MILK FAT endotoxic shock associated with infection, (pMRR10 and pMRR14 containing IC8 gL1, gL2

toxic intermediates or the use of toxic tin (CDCl3, 100 MHz) δ 146.8, 146.6, 134.9R13 and R15 is NO2 (R14 and R16 being H)

R14 is lower alkyl containing not more thanform or in the form of their non-toxic salts. 100 to 400 mg, especially 200 mg, of 4-

(CR14 R14)m -cycloalkyl, --(CR14 R14)m -100 mg/kg have been shown to inhibit tumor as well as nontoxic ammonium, quaternary

or R14 is Cl-C4alkyl substituted With 0 to For example, conventional non-toxic acid salts [0204] Homeopathic Therapies: Milk Thistle,

non-toxic acid addition salts, i.e., salts R14, R15 and R16 is hydrogen, m is zero, milk sugar as well as high molecular weight